FeatureASEAN

Hong Kong businesses are known for their flexibility and adaptability. A family-owned factory, now in its second generation, has faced constant challenges since the current owner took over the operation, so it took the decision to actively diversify.

Technology investors usually expect rapid returns on their assets, but the life sciences, especially medicine, have notoriously long development times. Returns can take decades to eventuate and ventures often turn out to be unviable.

Mainland China, the second-largest economy in the world, continues to draw strong market interest, especially in relation to the development of the Guangdong-Hong Kong-Macao Greater Bay Area (GBA).

The COVID-19 pandemic greatly accelerated digital transformation for many enterprises, bringing opportunities to consultancies that help companies make the transition.

Following the COVID-19 pandemic, companies are accelerating campaigns to upgrade brands, transform e-commerce systems and develop new production and supply chains to ensure they remain viable as long-term businesses.

In order to accelerate the integration of information and communication technology (ICT) to create an intelligent manufacturing industry, Hong Kong-based innovation and technology company Nexsen sees Industry 4.0 as an opportunity to actively expand into offshore markets.